GRMLNasdaq

Greenland Mines Ltd

Basic Materials·Basic Materials·Charlotte, NC, United States·CEO: Dr. Joseph A. Sinkule Pharm.D.

BioSniper AI · GRML

Greenland Mines Ltd is a mineral exploration company focused on gold, critical metals, and rare earths in Greenland, with a strategic investment in AnorTech for sustainable alumina and high purity alumina.

Key risk: Exploration-stage risk

Spotter reads the filings and answers with citations.

4.5/10

BioSniper Score

Based on 5 of 6 signals

Market Cap

$30.5M

Cash Runway

6.2 mo

Next Catalyst

Tracking 2 pipeline candidates for Greenland Mines Ltd · Updated within the last hour.

Similar companies

AI OverviewAI overview is shown in English only.

Greenland Mines Ltd is a mineral exploration company focused on gold, critical metals, and rare earths in Greenland, with a strategic investment in AnorTech for sustainable alumina and high purity alumina.

  • Rebranded from Klotho Neurosciences to Greenland Mines Ltd on March 12, 2026, changing Nasdaq ticker to GRML [news · published 2026-03-12].
  • Signed a definitive agreement on May 21, 2026 to acquire the Sarfartoq Nd-Pr rare earths project in southwest Greenland [news · published 2026-05-21].
  • Engaged Tetra Tech Canada Inc. and GeoSim Services Inc. to prepare an updated SEC S-K 1300-compliant mineral resource estimate for Sarfartoq [news · published 2026-06-18].
  • Signed a diamond drilling contract with Nordisk Fundering for an expanded 2026 field campaign at the Skaergaard precious and critical metals project [news · published 2026-06-22].
  • Acquired an initial 9.9% equity stake in AnorTech Inc. under a strategic share exchange agreement, with an option to increase ownership [news · published 2026-06-16].
  • Insider transactions include CEO Joseph Sinkule acquiring 2,500,000 shares at $0.00 on March 4, 2026, and director El-Dada Riad selling 175,000 shares at $0.23 on June 25, 2026 [insider_transaction].

What works

  • Multiple project advancements: Sarfartoq rare earths (Nd-Pr), Skaergaard gold/critical metals, and a strategic stake in AnorTech for sustainable alumina and HPA [news · published 2026-06-18][news · published 2026-06-22][news · published 2026-06-16].
  • Engaged reputable technical consultants (Tetra Tech, GeoSim, GTK Mintec, SLR Consulting, WSP) for resource estimates and development planning, signaling professional project management [news · published 2026-06-18][news · published 2026-06-25].
  • Secured a drilling contract for the 2026 Skaergaard program, indicating active field work and near-term data generation [news · published 2026-06-22].
  • Strategic investment in AnorTech provides optionality in critical mineral processing technologies (alumina, HPA) without direct ownership of those assets [news · published 2026-06-16].

What to weigh

  • Company recently rebranded from a biotech entity (Klotho Neurosciences) with no reported revenue or production; all projects are in exploration/development stage with no clear timeline to cash flow [news · published 2026-03-12].
  • Insider sale of 175,000 shares by a director at $0.23 on June 25, 2026, may signal a lack of confidence or need for liquidity [insider_transaction].
  • No financial data (cash, burn rate, accumulated deficit) is available in the provided chunks to assess the company's financial health or runway.
  • Greenland-based operations face regulatory, permitting, and geopolitical risks, and the company has not disclosed any mining licenses or production permits [news · published 2026-06-25].

From the filings

Quoted directly from source documents.

  • CEO Joseph Sinkule acquired 2.5 million shares at $0.00

    SINKULE JOSEPH (Chief Executive Officer) A 2500000 shares @ $0.00 on 2026-03-04

    Insider filings · March 4, 2026

Risks & what to watch (4)

Key risks

  • Exploration-stage riskAll projects are at exploration or development stage; no proven reserves or production. Resource estimates are preliminary and subject to change [news · published 2026-06-18].
  • Financing and cash burnNo financial data provided; the company likely has limited cash from a recent rebranding and must raise capital for drilling and development, diluting shareholders.
  • Greenland regulatory and permitting riskOperations in a remote, high-cost jurisdiction with evolving regulatory environment; no disclosed mining licenses or permits for Skaergaard or Sarfartoq [news · published 2026-06-25].
  • Insider sellingDirector sold 175,000 shares at $0.23 on June 25, 2026, which may indicate concern about valuation or liquidity [insider_transaction].

What to watch

  • Updated S-K 1300 resource estimate for Sarfartoq Nd-Pr project, expected from Tetra Tech and GeoSim [news · published 2026-06-18].
  • Results of the 2026 diamond drilling program at Skaergaard, under contract with Nordisk Fundering [news · published 2026-06-22].
  • Completion of the AnorTech share exchange and any exercise of the option to increase ownership beyond 9.9% [news · published 2026-06-16].
  • Any permitting or licensing developments for Greenland projects, following the technical workshop [news · published 2026-06-25].

Sources: Insider filings · News · Generated July 14, 2026 · How we verify sources →

Unlock the full Greenland Mines Ltd dossier

Sign in free to see catalysts, full pipeline, financials, FDA decisions, news, and run live AI deep-dives.

Free account includes:

  • Full pipeline, catalysts, financials & FDA decisions for Greenland Mines Ltd
  • 200 free AI credits / month to run live Spotter deep-dives
  • Watchlist, news alerts & the biotech event calendar
Sign in to unlock

Evidence & data

Score breakdownBased on 5 of 6 signals · derived from public data

Cash Runway1.7

6.2 months

Financial Health9.8

D/E 0.16 · 0% dilution

Pipeline Maturity2.0

Lead: Preclinical

Pipeline Breadth4.6

2 candidates

Catalyst MomentumN/A

No upcoming catalysts tracked

Insider Signal4.3

0 buys · 1 sell (180d)

Runway

Pipeline

Financials

Governance

Frequently asked questions

What is the AI investment thesis for Greenland Mines Ltd?

Greenland Mines Ltd is a mineral exploration company focused on gold, critical metals, and rare earths in Greenland, with a strategic investment in AnorTech for sustainable alumina and high purity alumina.

What is Greenland Mines Ltd's lead drug candidate?

Greenland Mines Ltd's most advanced tracked candidate is klto-101 (Preclinical) for Alzheimer's disease.

Who is the CEO of Greenland Mines Ltd?

Dr. Joseph A. Sinkule Pharm.D. is the chief executive officer of Greenland Mines Ltd (GRML).

Where is Greenland Mines Ltd headquartered?

Greenland Mines Ltd (GRML) is headquartered in Charlotte, NC, United States.

920 companies229,941 SEC filings19,412 clinical trials100% citation-verification pass rate (7d)How we verify →

The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.

Get the full picture on Greenland Mines Ltd

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.